SUMMARY
Activated Raf is a potent inhibitor of skeletal muscle gene transcription and myocyte formation through stimulation of downstream MAPK. However, the molecular targets of elevated MAPK with regard to myogenic repression remain elusive. We examined the effects of activated Raf on myogenin gene expression in avian myoblasts.
Overexpression of activated Raf in embryonic chick myoblasts prevented myogenin gene transcription and myocyte differentiation. Treatment with PD98059, an inhibitor of MEK, restored myogenin expression but did not reinstate the myogenic program. Using a panel of myogenin promoter deletion mutants, we were unable to identify a region within the proximal 829 bp promoter that confers responsiveness to MEK. Interestingly, our experiments identified MEF2A as a target of Raf-mediated inhibition in mouse myoblasts but not in avian myogenic cells. Embryonic myoblasts overexpressing activated Raf were unable to drive transcription from a minimal myogenin promoter reporter, containing a single E-box and MEF2 site, to levels comparable to controls.
Unlike mouse myoblasts, forced expression of MEF2A did not synergistically enhance transcription from the myogenin promoter in chick myoblasts indicating that additional molecular determinants of the block to myogenesis exist. Results of these experiments further exemplify specie differences in the mode of Raf-mediated inhibition of muscle differentiation. 
INTRODUCTION

METHODS AND MATERIALS
Plasmids
Expression plasmids coding for myc-tagged activated human Raf [pCS2+MT shuttle Raf BXB (CMV-Raf BXB), pCS2+MT shuttle Raf CAAX (CMV-Raf CAAX)] have been An Xba restriction site was included at the beginning of the 5' primer and a Bgl II restriction site was included on the 3' primer to allow for directional cloning into pGL2.
The fidelity of the reporters was verified by automated DNA sequencing. 
Cell culture and transient transfection
RNA Isolation and RT-PCR
RESULTS
Activated Raf inhibits myogenin expression. Early work demonstrated that constitutive
Ras activity leads to a loss of MRF expression in myocytes, which may contribute to the inhibitory effects of the kinase 21. Because Raf signaling is a product of Ras action and Raf is an inhibitor of myogenesis, we examined the relative amounts of myogenin protein in 
Activated Raf inhibits myogenesis by MEF2-dependent and independent mechanisms.
Recently, it was reported that an inducible Raf BXB inhibits L6 myoblasts from terminal differentiation and the block to myogenesis was a consequence of MEF2 localization to the cytoplasm 28. Raf CAAX inhibits the minimal myogenin promoter (-228mgn-Luc) and the region contains a single MEF2 DNA binding site (Figure 2) . To examine the effects of activated Raf on MEF2 and E-box function, each of the sites were mutated in the minimal promoter reporter to create -228mMEF2mgn-Luc and -228mEmgn-Luc, respectively. The promoter-reporters were transfected into ED10 myoblasts with pRL-CMV, CMV or CMV-Raf CAAX. After 48 hours, the cells were harvested and luciferase activities were measured. As shown in Figure 5 , both the wild type -228mgn- 
